{{item.videoDuration}}
{{item.title}}
{{item.text}}
{{item.videoDuration}}
{{item.text}}
Adragos Pharma acquires Sanofi’s Maisons-Alfort injectables manufacturing site, strengthening its position as a leading CDMO for injectable products in Europe.
PwC provided integrated buy-side Financial, Tax, Carve-out, Pensions, HR, IT, Labour Law, Legal and Regulatory Due Diligence services to Adragos Pharma to support the successful acquisition of Sanofi’s injectables manufacturing site in Maisons-Alfort, France. We also performed the purchase price allocation, supported with anti-trust analyses and tax structuring, and provided comments on the transaction documents.
Adragos Pharma is a fast-growing pharmaceutical CDMO focused on the development and manufacturing of pharmaceutical products, supporting clients across the full product lifecycle. The acquisition of the Maisons-Alfort site marks Adragos’ largest acquisition to date and a significant step in expanding its European manufacturing footprint and capabilities.
This leading commercial-scale sterile fill-finish site specialises in the production of injectable products, including pre-filled syringes and vials, and represents a strategic asset with strong technical capabilities and an established operational platform. Through this transaction, Adragos Pharma enhances its ability to serve a broad international customer base and further strengthens its position in the CDMO market.
The PwC team
Deals Financial Due Diligence
- Luca Borrelli (Partner)
- Vincent Luescher (Director)
- Manuel Belda Adell (Senior Manager)
- Oskar Bergdorf (Manager)
- Mathias Colpaert (Consultant)
Legal and Labour Law Due Diligence: PwC France team
- Claire Pascal-Oury (Partner)
- Antoine Coursaut-Durand (Partner)
- Carole Dessus (Partner)
- Aurélie Cluzel-d'Andlau (Partner)
Tax Due Diligence, Structuring
- Daniel Schmidt (Partner)
- Marco Fischer (Manager)
And a PwC France team led by
- Jérémie Schwarzenberg (Partner)
- Jitka Susankova (Partner)
- Bénédicte Le Maux (Partner)
Deals Carve-out & IT Due Diligence
- Alix Ekus (Director)
- Panya Viraphan (Managing Director)
- Erika Meta (Senior Manager)
- Ali Quenahat (Senior Manager)
- Manuel Dietrich (Senior Consultant)
Pensions & HR Due Diligence
- Kristi Leibur-Nagel (Partner)
- Navaz Djadaoudjee (Director)
- Linda Kennou (Director)
- Ester Lamerikx (Senior Manager)
- Yvey Frey (Manager)
- Patricia Nlom (Manager)
- Lucy Aspinall-Kraft (Senior Consultant)
- Cédric Spadetti (Senior Consultant)
Regulatory Due Diligence
- Sandra Ragaz (Partner)
- Jean-Pierre Anzevui (Director)
- Nicole Giesbrecht (Senior Manager)
- Dominique Thierry (Senior Manager)
- Dominik Hofstetter (Manager)
- Tafadzwa Mlambo Stolarz (Senior Consultant)
And a PwC France team led by
- Antoine Coursaut-Durand (Partner)
Purchase Price Allocation (PPA)
- Dirk Kadel (Partner)
- Thomas Schneller (Director)
- Ekaterina Kushnir (Senior Manager)
- Miguel Garcia Martinez (Manager)
- Philipp Schaer (Senior Consultant)
